← Back to patent-cliff list
CAS 112-82-3
1-Bromohexadecane1-bromohexadecane
Codes: Miltefosine-003, CI-201-001
Application context (from source-drug indications)
利什曼原虫感染Miltefosine皮肤利什曼病MiltefosineChronic urticariaMiltefosine内脏利什曼病Miltefosine粘膜皮肤利什曼病MiltefosineCOVID-19VB-201HIV infectionVB-201Cardiac and vascular disordersVB-201Inflammatory diseaseVB-201Ulcerative colitisVB-201PsoriasisVB-201
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Miltefosine | Tier C — Watch / trade | - |
| VB-201 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
[2-(Trimethylaminio)ethyl] hydrogen phosphate→[2-(trimethylazaniumyl)ethyl] hydrogen phosphate→1-Bromohexadecane
1-bromohexadecane→(R)-(2,2-dimethyl-1,3-dioxolan-4-yl)methanol→(S)-3-(hexadecyloxy)propane-1,2-diol→(R)-1-(hexadecyloxy)-3-(trityloxy)propan-2-ol→hex-5-en-1-yl methanesulfonate→(R)-((2-(hex-5-en-1-yloxy)-3-(hexadecyloxy)propoxy)methanetriyl)tribenzene→(S)-2-(hex-5-en-1-yloxy)-3-(hexadecyloxy)propan-1-ol→2-bromoethyl phosphorodichloridate→(R)-2-(hex-5-en-1-yloxy)-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate→(R)-3-(hexadecyloxy)-2-((5-oxopentyl)oxy)propyl (2-(trimethylammonio)ethyl) phosphate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.